Angiotensin-converting enzyme inhibition after myocardial infarction: the trandolapril cardiac evaluation study
- 31 July 1996
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 132 (1) , 235-243
- https://doi.org/10.1016/s0002-8703(96)90559-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1995
- Clinical Characteristics and Mortality of Patients Screened for Entry Into the Trandolapril Cardiac Evaluation (TRACE) StudyThe American Journal of Cardiology, 1995
- ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarctionThe Lancet, 1995
- An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study)European Heart Journal, 1994
- The TRAndolapril Cardiac Evaluation (TRACE) study: Rationale, design, and baseline characteristics of the screened populationThe American Journal of Cardiology, 1994
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Rapid Estimation of Left Ventricular Ejection Fraction in Acute Myocardial Infarction by Echocardiographic Wall Motion AnalysisCardiology, 1992
- Early estimation of risk by echocardiographic determination of wall motion index in an unselected population with acute myocardial infarctionThe American Journal of Cardiology, 1990
- Cross-sectional echocardiographic analysis of the extent of left ventricular asynergy in acute myocardial infarction.Circulation, 1980